MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'diet drug'. Sat, 03 Sep 2011 02:58:08 +0100 http://www.medworm.com/index.php?rid=4780486&cid=t_446073_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FIjq9ZMQ6Rf4%2F Anxious to win FDA approval for its Qnexa diet pill, Vivus has come up with an unsual fallback position to overcome safety issues that have so far scuttered agency endorsement. If the results of a planned teratogenicity study are inadequate to win over regulators, the beleaguered little drugmaker plans to seek a limited indication. Very limited. This would involve allowing docs to prescribe the diet pill to “only men and women of non-child bearing potential” (read here). This might seem counterintuitive. After all, diet pills are widely sought by countless women who are still capable of conceiving. For instance, Leerink Swann analyst Steve Yoo estimates in an investor note this morning that about 50 percent of the “likely market could fall into the women of childbearing a... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4780486 Tue, 03 May 2011 13:07:13 +0100 4780486 http://www.medworm.com/index.php?rid=4715016&cid=t_446073_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FYiEPmFQ6yMo%2F And so another work week will soon draw to a close. This means, of course, the time has come to daydream about weekend plans. Our agenda includes spring cleaning, taking one of our short people to a soccer match and catching up on some sleep. What about you? Anything special planned? A walk in the park? Reaching out to an old friend? Maybe planning the rest of your life? Whatever you do, have a great time. Meanwhile, here are some tidbits. Catch you soon… EU Backs Boehringer Pradaxa Stroke Prevention Drug (Reuters) US Will Negotiate Medicare Drug Prices: Obama (Pharma Times) EU OKs Bydureon Diabetes Med From Lilly & Amylin (Reuters) Genzyme MS Drug Shows Promising Five-Year Results (Mass High Tech) Glaxo To Sell Plant And Eliminate 250 Jobs (Memphis Business Journal) Glaxo To Se... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4715016 Fri, 15 Apr 2011 11:33:47 +0100 4715016 http://www.medworm.com/index.php?rid=4715020&cid=t_446073_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FcEBOhpGUe_M%2F For the second time in five years, Public Citizen is petitioning the FDA to ban the Xenical prescription diet pill sold by Roche, which is also marketed in a lower-dose, over-the-counter version as Alli by GlaxoSmithKline. The latest move comes after a report earlier this week that linked the drug to kidney stones and pancreatic damage. The watchdog group identified 47 cases of acute pancreatitis and 73 kidney stones among patients taking either the prescription version or the over-the-counter form. Last year, the FDA added warnings to Xenical and Alli about rare reports of liver damage - 12 reports of severe liver toxicity associated with Xenical and one domestic case for Alli. Two of the patients died of liver failure and three required liver transplants. Public Citizen wants the manufac... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4715020 Thu, 14 Apr 2011 14:49:30 +0100 4715020 http://www.medworm.com/index.php?rid=4709424&cid=t_446073_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FpR8BdZuodiU%2F Hello, everyone, and nice to see you again. A spot of rain is falling on the Pharmalot corporate campus, but as you know, our spirits are as sunny as ever and reinforced by a bit of wisdom from the Morning Mayor: ‘Every brand new day should be unwrapped like a precious gift.’ So while we down our cup of stimulation, we present the news of the world in hopes this will help you cope with those meetings and deadlines. Have a great day and give someone a big smile… BioSante Says FDA Accepts Filing For Male Testerone Gel (Reuters) Merck To Outsource Work Done At Pennsylvania Plant (The Daily Item) Novartis Drug Wins FDA Panel OK For Rare Pancreatic Tumors (Bloomberg News) Pfizer Drug Wins FDA Committee Backing For Pancreatic Cancer (Bloomberg News) Roche’s Xenical Diet P... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4709424 Wed, 13 Apr 2011 12:12:07 +0100 4709424 http://www.medworm.com/index.php?rid=4406030&cid=t_446073_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fu6wIn052s0o%2F Reeling from setbacks in obtaining approval for its Lorqess diet pill, Arena Pharmaceutical is laying off 66 employees - about 25 percent of its workforce - and continues to maintain that a resubmission can be filed with the FDA by the end of the year. However, the drugmaker could not guarantee the deadline can be met and offered a laundry list of issues to first resolve with FDA staffers. The list includes what the drugmaker deemed as “non-clinical issues” involving ties between Lorqess and tumors in rats, a notion that has plagued Arena executives for months, especially after Arena ceo Jack Lief was criticized for failing to more thoroughly vet the topic with investors prior to the rejection by the FDA advisory panel last September (see this). In a statement, Arena says five ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4406030 Thu, 27 Jan 2011 22:34:16 +0100 4406030 http://www.medworm.com/index.php?rid=3868937&cid=t_446073_180_f&fid=38612&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fpickthebrain%2FLYVv%2F%7E3%2FqbTzwDVHOnc%2F This article is for informational purposes only and is not to be interpreted as medical advice. If seeking medical advice, consult a licensed physician. Don’t forget to follow PTB on Twitter! : Overcoming Addiction and Escapism 5 Reasons Your Life Will Improve Through Writing 10 All Natural Ways To Stop Feeling Depressed A Muscle Building Work Out You Can Do Without Weights (Source: PickTheBrain | Motivation and Self Improvement) PickTheBrain | Motivation and Self Improvement blogs http://www.medworm.com/rss/comments.php?id=3868937 Mon, 16 Aug 2010 05:38:04 +0100 3868937 http://www.medworm.com/index.php?rid=3153630&cid=t_446073_150_f&fid=38374&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2FiOJS9qmBLf4%2Fdiet-drug-maker-glaxo-to-pay-for-film.html (Source: ePharma Summit) ePharma Summit blogs http://www.medworm.com/rss/comments.php?id=3153630 Fri, 08 Jan 2010 16:41:00 +0100 3153630 http://www.medworm.com/index.php?rid=682737&cid=t_446073_87_f&fid=34865&url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F06%2F19%2Fdiet-drug-xenical-renamed-alli-still-a-cancer-worry%2F Filed under: Breast Cancer, Drug, Colon and Rectal Cancer, Daily newsPrescription weight-loss drug Xenical hit drugstore shelves on Friday with a new name -- Alli (pronounced: "Al-eye") and with a new non-prescription strength. The newly-named drug is to be more effective with less unpleasureable side effects. Still, there's a problem surrounding this drug, regardless of its name. It's thought to cause colon cancer.The nonprofit group Public Citizen says Alli, made by GlaxoSmithKline, has been shown in mice studies to cause pre-cancerous lesions in the colon. Since there are no long-term studies on humans, this group believes the FDA should not have approved the drug for non-prescription use. It's not clear whether or not the pre-cancerous spots will lead to colon cancer but the mere sugge... The Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=682737 Tue, 19 Jun 2007 04:00:00 +0100 682737